Search

everythinglearnresearchcommunity

for

Search:↓

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Ayurvedic treatment improved PCOS symptoms in a 40-year-old woman.

High testosterone increases heart disease risk in women with PCOS.

Women with prediabetes may have a higher risk of PCOS-like changes, especially if they have impaired glucose tolerance.

Procyanidin B2 and leucopelargonidin from Saraca asoca may help treat PCOS by balancing hormones.

Hair loss may increase heart disease risk.

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Both genetic and lifestyle factors significantly affect female hair loss.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Obese women with PCOS are more likely to have fatty liver disease.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

CD146 + mesenchymal stem cells are more effective for treating premature ovarian failure.

Accurate diagnosis is crucial to distinguish between PCOS and rare ovarian tumors in teens with similar symptoms.

The study found that PCOS affects about 6.5-6.8% of women in both urban and rural areas of Telangana, India, and highlighted the importance of lifestyle changes for management.